MobiHealth News April 26, 2024
Jessica Hagen

The pharma giant’s employees will have access to ChatGPT Enterprise, which allows teams to create customized GPTs on specific topics.

OpenAI and Moderna announced the pair have expanded their partnership to offer the pharma giant’s employees access to ChatGPT Enterprise, a platform that allows customizable GPTs to be developed for a specific purpose.

Through ChatGPT Enterprise, users can create GPTs by beginning a conversation with ChatGPT, then providing extra knowledge on a subject or giving it instructions. Users can also choose what the GPT can do, such as analyzing data, searching the web or making images.

Moderna, which initially partnered with OpenAI in early 2023, tested the deployment of ChatGPT Enterprise within its workforce, allowing individual teams to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Technology, Trends
Related Articles:
AI Investments Expected to Shift to Inference While Growing Faster Than Forecast
Report: OpenAI to Test Feature Connecting ChatGPT to Slack and Google Drive
Vaccines And AI
Mistral AI drops new open-source model that outperforms GPT-4o Mini with fraction of parameters
The most 'impactful' tech in 30 years? Ask Duke's health information chief

Share This Article